Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Multiple-Center, Observer-Blinded, Randomized, Placebo-Controlled, Single And Multiple Ascending Dose Study to Investigate the Pharmacokinetics, Pharmacodynamics, Safety, Tolerability, And Food Effect of RO5024048 [RG 7128] in Healthy Volunteers And in Patients With Chronic HCV [hepatitis C virus] Infection.

Next Previous
X
Search
Trial Profile

A Multiple-Center, Observer-Blinded, Randomized, Placebo-Controlled, Single And Multiple Ascending Dose Study to Investigate the Pharmacokinetics, Pharmacodynamics, Safety, Tolerability, And Food Effect of RO5024048 [RG 7128] in Healthy Volunteers And in Patients With Chronic HCV [hepatitis C virus] Infection.

Status: Completed
Phase of Trial: Phase I/II

Latest Information Update: 15 Apr 2010

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Mericitabine (Primary) ; Peginterferon alfa-2a; Ribavirin
  • Indications Hepatitis C
  • Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
  • Sponsors Pharmasset

    • Most Recent Events

    • 13 Apr 2010 Follow-up data from cohort 4 will be presented at the 45th Annual Meeting of the European Association for the Study of the Liver, according to a Pharmasset media release.
    • 25 Apr 2009 Status changed from recruiting to completed, according to ClinicalTrials.gov.
    • 08 Sep 2008 Preliminary results from the fourth cohort reported in a Pharmasset media release.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top